Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07574021
The Experience of Short Video Addiction Among College StudentsSun Yat-sen UniversityNot Yet Recruiting
NCT07574021Not Yet Recruiting
—
The Experience of Short Video Addiction Among College StudentsSun Yat-sen University
NCT07573137
Hard Splint Vs Conservative Therapy for TMJ Pain ManagementKhyber College of dentistryNot Yet RecruitingNot Applicable
NCT07573137Not Yet Recruiting
Not Applicable
Hard Splint Vs Conservative Therapy for TMJ Pain ManagementKhyber College of dentist...
NCT07572552
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With SepsisTanta UniversityNot Yet RecruitingPhase 2
NCT07572552Not Yet Recruiting
Phase 2
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymar...Tanta University
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573592
Clinical Evaluation of an Atopic Skin Product Containing Picea Abies Resin ExtractBusiness FinlandCompletedNot Applicable
NCT07573592Completed
Not Applicable
Clinical Evaluation of an Atopic Skin Product Containing Picea Abies Resin Extra...Business Finland
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07572747
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesKhalid F AlhabibNot Yet RecruitingPhase 3
NCT07572747Not Yet Recruiting
Phase 3
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countrie...Khalid F Alhabib
NCT07572656
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe PreeclampsiaMuhammad Aamir LatifCompletedNot Applicable
NCT07572656Completed
Not Applicable
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preecl...Muhammad Aamir Latif
NCT07573033
Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibular 3rd Molar Surgery.Liaquat College of Medicine and DentistryCompletedPhase 4
NCT07573033Completed
Phase 4
Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibul...Liaquat College of Medici...
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07573787
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste DisordersChristoph GrimmTerminatedNot Applicable
NCT07573787Terminated
Not Applicable
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste Dis...Christoph Grimm
NCT07572058
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLCNot Yet RecruitingNot Applicable
NCT07572058Not Yet Recruiting
Not Applicable
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLC
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07572448
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sense Of SafetyUludag UniversityNot Yet Recruiting
NCT07572448Not Yet Recruiting
—
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sens...Uludag University
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573358
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patients With Bell's PalsyCairo UniversityNot Yet Recruiting
NCT07573358Not Yet Recruiting
—
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patie...Cairo University
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07572591
Ultrasound for Peripheral Nerve ModulationStanford UniversityNot Yet RecruitingNot Applicable
NCT07572591Not Yet Recruiting
Not Applicable
Ultrasound for Peripheral Nerve ModulationStanford University
NCT07571980
The Effects of Low-Flow and Normal-Flow Sevoflurane Anesthesia on Frontal QRS-T Angle and TP-e IntervalIstanbul UniversityNot Yet Recruiting
NCT07571980Not Yet Recruiting
—
The Effects of Low-Flow and Normal-Flow Sevoflurane Anesthesia on Frontal QRS-T...Istanbul University
Result Breakdown
Not yet recruiting15 (75%)
Completed3 (15%)
Recruiting1 (5%)
Terminated1 (5%)
not_applicable7 (35%)
Not Specified5 (25%)
Phase 23 (15%)
Phase 12 (10%)
Phase 42 (10%)
Phase 31 (5%)